Ex Parte Swei et alDownload PDFPatent Trial and Appeal BoardFeb 9, 201713755078 (P.T.A.B. Feb. 9, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/755,078 01/31/2013 Jason Swei 83140761 9421 22879 HP Tnr 7590 02/13/2017 EXAMINER 3390 E. Harmony Road Mail Stop 35 SASTRI, SATYA B FORT COLLINS, CO 80528-9544 ART UNIT PAPER NUMBER 1762 NOTIFICATION DATE DELIVERY MODE 02/13/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): ipa.mail@hp.com barbl@hp.com y vonne.bailey @ hp. com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte JASON SWEI, HAIGANG CHEN, and BOR-JIUNN NIU Appeal 2015-007047 Application 13/755,078 Technology Center 1700 Before BEVERLY A. FRANKLIN, KAREN M. HASTINGS, and DEBRA L. DENNETT, Administrative Patent Judges. HASTINGS, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Appellants1 seek our review under 35 U.S.C. § 134(a) of the Examiner’s final decision rejecting claims 1, 3—8, 16, and 17. We have jurisdiction over the appeal under 35 U.S.C. § 6(b). We AFFIRM. Independent claim 1 is illustrative (emphasis added): 1. A pre-treatment coating, comprising: a solvent; a matrix, including: 1 The real party in interest is stated to be Hewlett-Packard Development Company, LP (App. Br. 3). Appeal 2015-007047 Application 13/755,078 from 50 wt.% to 80 wt.% of a polyvalent metal salt, and from 5 wt.% to 20 wt.% of a latex having a Tg below 100 °C; and wax particles at from 5 wt. % to 30 wt. %, wherein weight percentages of the polyvalent metal salt, the latex, and the wax particles are based on a total amount of solids present in the pre-treatment coating after removal of the solvent, and wherein the pre-treatment coating is formulated so that at least a portion of the wax particles have a particle size that is greater than an average thickness of the matrix when applied to a media substrate. The following rejections have been maintained by the Examiner2: a. claims 1, 3, 4, 6—8, 16, and 17 as unpatentable under pre-AIA 35 U.S.C. § 102(e) as being anticipated by Dannhauser et al. (US 2013/0293647 Al, published Nov. 7, 2013) (hereinafter “Dannhauser”); b. claims 1,3,4, 6—8, 16, and 17 are unpatentable under pre-AIA 35 U.S.C. § 103(a) as being unpatentable over Dannhauser; and c. claim 5 is unpatentable under pre-AIA 35 U.S.C. § 103(a) as being unpatentable over Dannhauser in combination with Sarkisian et al. (US 2011/0303113 Al, published Dec. 15, 2011) (hereinafter “Sarkisian”). ANALYSIS We have reviewed each of Appellants’ arguments for patentability. However, we determine that a preponderance of the evidence supports the 2 The Examiner withdrew the rejections made under 35 U.S.C. § 112 (pre- AIA) (Ans. 7). 2 Appeal 2015-007047 Application 13/755,078 Examiner’s finding that the claimed subject matter of independent claim 1 is anticipated within the meaning of § 102 in view of the applied prior art, and also unpatentable under 35 U.S.C. § 103. Accordingly, we will sustain the Examiner’s §§ 102 and 103 rejections, as well as the Examiner’s § 103 rejections for essentially those reasons expressed in the Answer, including the Examiner’s Response to Argument section, and we add the following primarily for emphasis. The §102 and §103 Rejections Appellants’ principal argument is that since Dannhauser does not disclose the glass transition temperature (Tg) of its latex component, and since different latexes may have different properties, claim 1 is not anticipated (App. Br. 21, 22; Reply Br. 6) nor is dependent claim 17 (App. Br. 23). Appellants also argue (with respect to the alternative rejection of the claims under § 103) that there is no guidance to carve out from the disclosure of Dannhauser such a latex with a glass transition temperature as recited in claim 1 (or dependent claim 17) since no such latex has been identified by the Examiner (App. Br. 27, 28). Each argument advanced by Appellants is adequately addressed by the Examiner (Ans. generally). As pointed out by the Examiner, there is a reasonable basis to expect that at least some of the latexes described in Dannhauser would have the recited glass transition temperature (Ans. 8; explaining that the latexes as claimed in claim 4 and disclosed in the Specification overlap the latexes described in Dannhauser for the very same purpose as Appellants’ of a pretreatment composition for inkjet printing). Likewise the Examiner’s position that at least some of the waxes described 3 Appeal 2015-007047 Application 13/755,078 in Dannhauser would have reasonably been expected to exhibit the melting point claimed in dependent claim 16 is reasonable (e.g., Ans. 9), contrary to Appellants’ arguments (App. Br. 22, 23; Reply Br. 7). Notably, Appellants have not directed our attention to any persuasive reasoning or credible evidence to establish that the Examiner’s determination that at least some of the compositions disclosed in Dannhauser will inherently result in the claimed properties is incorrect (App. Br. 22—29; Reply Br. generally). It is well settled that when a claimed product reasonably appears to be substantially the same as a product disclosed by the prior art, the burden is on the applicant to prove that the prior art product does not necessarily or inherently possess characteristics attributed to the claimed product, and that it is of no moment whether the rejection is based on § 102 or § 103 since the burden is on the applicant is the same. In re Spada, 911 F.2d 705, 708 (Fed Cir. 1990); In re Best, 562 F.2d 1252, 1255 (CCPA 1977) (mere recitation of newly discovered function or property inherently possessed by prior art does not cause a claim to distinguish over the prior art; where claimed and prior art products are identical or are produced by identical processes, the Patent and Trademark Office can require an applicant to prove that the prior art products do not necessarily or inherently possess the characteristics of the claimed product).3 3 Cf. In re Schreiber, 128 F.3d 1473, 1478 (Fed. Cir. 1997) (It is well established where there is reason to conclude that the structure of the prior art is inherently capable of performing the claimed function, the burden shifts to the applicant to show that the claimed function patentably distinguishes the claimed structure from the prior art structure.) 4 Appeal 2015-007047 Application 13/755,078 Appellants do not sufficiently point out any error in the Examiner’s obviousness determination of dependent claim 5 (e.g., App. Br. 29, 30; Ans. 11,12). Appellants’ reliance on the examples in the Specification to evince unexpected results from the use of a latex having a Tg as recited in dependent claim 17 (App. Br. 28, 29; Reply Br. 10) are not persuasive of error. The burden of showing unexpected results rests on the person who asserts them by establishing that the difference between the claimed invention and the closest prior art was an unexpected difference. See In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. Cir. 1991); In re Klosak, 455 F.2d 1077, 1080 (CCPA 1972). The unexpected results must be established by factual evidence, and attorney statements are insufficient to establish unexpected results. See In re Geisler, 116 F.3d 1465, 1470—71 (Fed. Cir. 1997). Further, a showing of unexpected result supported by factual evidence must be reasonably commensurate in scope with the degree of protection sought by the claims on appeal. In re Grasselli, 713 F.2d 731, 743 (Fed. Cir. 1983); In re Clemens, 622 F.2d 1029, 1035 (CCPA 1980). Appellants have not met their burden of showing unexpected results for at least the reasons set out by the Examiner (Ans. 12). Moreover, we do not find Appellants’ contention that there are unexpected results supporting the patentability of claim 17 which recites a limited Tg for the latex component of the composition to be well-founded. Critically, Appellants do not direct us to any statement in the Specification attesting to the unexpected nature of the results from the use of a latex having this property or to any persuasive evidence that the results obtained would have been unexpected at the time of the invention. Absent such, 5 Appeal 2015-007047 Application 13/755,078 Appellants cannot meet their burden. See, e.g., In re Geisler, 116 F.3d at 1471 (Fed. Cir. 1997) (“Geisler made no such assertion [that results were unexpected] in his application. Nor did Geisler submit any such statement through other evidentiary submissions, such as an affidavit or declaration under Rule 132. .. . Instead, the only reference to unexpected results was a statement by Geisler’s counsel. . . that Geisler’s results were ‘surprising.’”)4. Accordingly, the Examiner’s §§102 and 103 rejections are affirmed with respect to all of the claims on appeal. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136. ORDER AFFIRMED 4 Indeed, Appellants’ Specification focuses on the use of a specific relative size of the wax particles in a pre-treatment coating (e.g., Spec. 17), and there is no dispute that Dannhauser discloses the claimed wax particle size relationship (App. Br., Reply Br. generally, e.g., Ans. 3). 6 Copy with citationCopy as parenthetical citation